Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-09-21), EP Biocomposites's 14-Day RSI is 51.98.
The industry rank for EP Biocomposites's 14-Day RSI or its related term are showing as below:
BOM:543595's 14-Day RSI is ranked worse than 64.05% of 1897
companies
in the Construction industry
Industry Median: 47.96
vs BOM:543595: 51.98
EP Biocomposites (BOM:543595) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
EP Biocomposites 14-Day RSI Related Terms
BOM:543595 vs TT, JCI, CARR: 14-Day RSI Comparison
For the Building Products & Equipment subindustry, EP Biocomposites's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EP Biocomposites 14-Day RSI vs Construction Industry
For the Construction industry and Industrials sector, EP Biocomposites's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where EP Biocomposites's 14-Day RSI falls into.
EP Biocomposites (BOM:543595) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EP Biocomposites (BOM:543595) has a 14-Day RSI of 51.98 as of Sep. 21, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on EP Biocomposites and its competitors. According to the industry distribution chart, EP Biocomposites ranks #1215 out of 1897 companies in the Construction industry, placing it in the top 64%.
Is EP Biocomposites' 14-Day RSI too high?
EP Biocomposites' current 14-Day RSI is 51.98. The Construction industry median 14-Day RSI is 47.96. EP Biocomposites' value of 51.98 is 8.4% above this industry median. Based on the distribution chart, EP Biocomposites ranks #1215 out of 1897 companies in the Construction industry, which is below the industry midpoint. Overall, EP Biocomposites has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' 14-Day RSI compare to TT and JCI?
According to the Construction industry distribution chart, EP Biocomposites ranks #1215 out of 1897 companies for 14-Day RSI. This places EP Biocomposites in the lower half of its industry. The industry median 14-Day RSI is 47.96. EP Biocomposites' value of 51.98 is 8.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Construction company?
The median 14-Day RSI among Construction companies is 47.96, based on 1,897 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EP Biocomposites's current 14-Day RSI of 51.98 is 8.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on EP Biocomposites and its competitors. For the Construction industry, the median 14-Day RSI is 47.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EP Biocomposites's current 14-Day RSI is 51.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹206.80, compared to a current price of ₹100.00 — trading 51.6% below its estimated fair value. The current 14-Day RSI is 51.98 and 8.4% above the Construction industry median of 47.96. EP Biocomposites' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current 14-Day RSI is 51.98 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EP Biocomposites (BOM:543595) Overvalued in 2026?
Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued.
The current stock price of ₹100.00 is trading 51.6% below its estimated GF Value™ of ₹206.80.
GuruFocus considers EP Biocomposites to be Significantly Undervalued.
Key valuation signals for BOM:543595:
14-Day RSI: 51.98
GF Value™: ₹206.80 vs. price of ₹100.00 (51.6% below fair value)
Industry Position: 8.4% above the Construction median (#1215 of 1897)
No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
77GF Score
Get the complete analysis for BOM:543595
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543595 has been successfully added to your 
